Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine.

Human vaccines & immunotherapeutics - 2 Dec 2021

Singh Abhay, Kumar Sachin

Abstract excerpt

The circulating variants of SARS-CoV-2 pose a threat to the public health response worldwide, especially in the case of developing countries, lacking vaccines and having compromised health-care facilities. This article highlights several recent studies conducted to determine the efficacy of COVID-19 vaccines against variants of concern. These studies comprise clinical trials and neutralization assay-based studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to COVID-19 Vaccines
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to SARS-CoV-2

Share to Vaccines, Inactivated

Source

Open in PubMed Open full text

Identifiers

PMID: 34856855
DOI: 10.1080/21645515.2021.1997487
PMCID: PMC8903907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine.PMID 34856855Read ↗

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.Semantic proximity Read ↗

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19Semantic proximity Read ↗

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic StrategiesSemantic proximity Read ↗

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum ProtectionSemantic proximity Read ↗

The Variation of SARS-CoV-2 and Advanced Research on Current VaccinesSemantic proximity Read ↗

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 VariantsSemantic proximity Read ↗

COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants.Semantic proximity Read ↗

Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2Semantic proximity Read ↗

Vaccine efficacy in mutant SARS-CoV-2 variants.Semantic proximity Read ↗

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited AntibodiesSemantic proximity Read ↗

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine EfficacySemantic proximity Read ↗

The COVID-19 pandemic: viral variants and vaccine efficacySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.